UCB

09.09.2024 – 07:00
New insights highlight unmet needs for people living with Lennox-Gastaut syndrome and significant burden of the disease
Brussels (ots/PRNewswire) - - New data presented at the 15th European Epilepsy Congress highlight lengthy delays in Lennox-Gastaut syndrome (LGS) diagnosis in Europe and significant disease burden from both seizure and non-seizure impairments[1] - LGS is a severe childhood-onset developmental and epileptic ...
mehr
22.09.2005 – 07:01
European Commission Approves Use of Anti-Epileptic Keppra(R) as Adjunctive Therapy in Children Four Years of Age and Older With Partial-Onset Seizures
Brussels, Belgium (ots/PRNewswire) - Today UCB announced that the European Commission has approved the use of Keppra(R) (levetiracetam) in the European Union, as adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalisation, in children from four to sixteen years of ...
mehr